National and Kapodistrian University of Athens
Μοριακή σταδιοποίηση στον καρκίνο της κύστης
Abstract
dc:descriptionBladder Cancer (BC) is a lethal disease with many social and financial consequencesin our time. Despite the modern diagnostic tecniques and therapeutic approaches, theoverall mortality and morbidity is quite high. Early diagnosis, accurate staging, andoptimal treatment strategy are prerequisites for good prognosis of the disease. Themain staging and prognostic criteria of bladder cancer are derived from clinical data,histology and radiology that often lead to poor diagnosis and high incidence ofundestaging the disease in many patients. Recently there has been a lot of research inan effort to determine and detect specific molecular markers in blood, that can beused for early diagnosis of the disease, identify the effectiveness of treatment, andfollow up of patients after treatment with curative intent for identification of earlyreccurence. Under this spectrum the detection of circulating bladder cancer cells(CBC) in blood and urine, is a potential marker of reccurence, subclinical residualdisease that can lead to metastasis and cannot be detected with conventional methods.The aim of this study is:Confirmation of simultaneous mRNA detection of multiple molecular cancer markersusing RT-Multiplex PCR, in blood and urine specimens, and their combination forthe detection of circulating bladder cancer cells (CBC).The creation of a non invasive feasible technique in everyday clinical practice that candetermine fast and accurately those patients that has been understaged usingconventional methods.In the current study we examined a group of special markers for bladder cancer in aneffort to detect mRNA in blood and urine samples of patients with bladder cancer. Wehave chosen as markers the cytokeratines CK19, CK20, the epidermal growth factorreceptor (EGFR), Mucin 7 in the blood samples of patients and cytokeratine CK20,HTERT, Survivin in urine samples of patients and GAPDH as internal control of theexperiment. A protocol has been set up to find the efficiency of our technique byspiking, in tissue with known bladder cancer and healthy controls. Then MultiplexPCR protocol has been developed and we achieved detection of the markers used in30 patients with bladder cancer of different stage with no detection of the markers inthe 30 healthy controls.In conclusion, we can detect the circulating bladder cancer cells with the markersstudied in blood and urine of patients with bladder cancer without detection of them inhealthy controls. It seems that there is correlation between the number of the markersdetected and the stage of the disease and also the detection of these markers mayaffect the mortality of the disease. The sensitivity of the method can be increased iffor a test to be considered positive only detection of one marker will suffice and thespecificity of the method can increase if for a test to be considered positive all themarkers that are being tested must be detected. Overall, we have set up a noninterventional, low cost, easy and reliable protocol that could help the clinician tospecify more accurately the stage of the disease and the prognosis of each patient.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Dimopoulos, Panagiotis
- Δημόπουλος, Παναγιώτης
Subjects
dc:subject × 17Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/29562